KROS
Price
$13.45
Change
+$0.04 (+0.30%)
Updated
Jul 3 closing price
Capitalization
546.28M
25 days until earnings call
XERS
Price
$4.75
Change
+$0.02 (+0.42%)
Updated
Jul 3 closing price
Capitalization
760.74M
31 days until earnings call
Interact to see
Advertisement

KROS vs XERS

Header iconKROS vs XERS Comparison
Open Charts KROS vs XERSBanner chart's image
Keros Therapeutics
Price$13.45
Change+$0.04 (+0.30%)
Volume$148.11K
Capitalization546.28M
Xeris Biopharma Holdings
Price$4.75
Change+$0.02 (+0.42%)
Volume$1.08M
Capitalization760.74M
KROS vs XERS Comparison Chart in %
Loading...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KROS vs. XERS commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KROS is a Hold and XERS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (KROS: $13.45 vs. XERS: $4.75)
Brand notoriety: KROS and XERS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KROS: 22% vs. XERS: 51%
Market capitalization -- KROS: $546.28M vs. XERS: $760.74M
KROS [@Biotechnology] is valued at $546.28M. XERS’s [@Biotechnology] market capitalization is $760.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KROS’s FA Score shows that 1 FA rating(s) are green whileXERS’s FA Score has 0 green FA rating(s).

  • KROS’s FA Score: 1 green, 4 red.
  • XERS’s FA Score: 0 green, 5 red.
According to our system of comparison, KROS is a better buy in the long-term than XERS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KROS’s TA Score shows that 3 TA indicator(s) are bullish while XERS’s TA Score has 6 bullish TA indicator(s).

  • KROS’s TA Score: 3 bullish, 6 bearish.
  • XERS’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, XERS is a better buy in the short-term than KROS.

Price Growth

KROS (@Biotechnology) experienced а -0.44% price change this week, while XERS (@Biotechnology) price change was +0.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

KROS is expected to report earnings on Jul 31, 2025.

XERS is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XERS($761M) has a higher market cap than KROS($546M). XERS YTD gains are higher at: 40.118 vs. KROS (-15.035). KROS has higher annual earnings (EBITDA): 14.8M vs. XERS (-4.34M). KROS has more cash in the bank: 721M vs. XERS (58.4M). KROS has less debt than XERS: KROS (18.4M) vs XERS (269M). XERS (223M) and KROS (215M) have equivalent revenues.
KROSXERSKROS / XERS
Capitalization546M761M72%
EBITDA14.8M-4.34M-341%
Gain YTD-15.03540.118-37%
P/E RatioN/AN/A-
Revenue215M223M96%
Total Cash721M58.4M1,235%
Total Debt18.4M269M7%
FUNDAMENTALS RATINGS
XERS: Fundamental Ratings
XERS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KROSXERS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
75%
Momentum
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
79%
MACD
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 7 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
79%
Aroon
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCPIX51.330.43
+0.84%
DWS S&P 500 Index S
TMPIX57.210.19
+0.33%
Touchstone Mid Cap Institutional
MAGRX33.10-0.01
-0.03%
BlackRock Natural Resources Instl
TBWIX21.24-0.08
-0.38%
Thornburg Better World International I
RYESX179.67-0.93
-0.51%
Rydex Energy Services A

KROS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KROS has been loosely correlated with INZY. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if KROS jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KROS
1D Price
Change %
KROS100%
+0.30%
INZY - KROS
43%
Loosely correlated
N/A
DNLI - KROS
39%
Loosely correlated
-1.41%
XNCR - KROS
38%
Loosely correlated
+1.45%
ALT - KROS
38%
Loosely correlated
-2.86%
XERS - KROS
38%
Loosely correlated
+0.42%
More

XERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, XERS has been loosely correlated with TRDA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if XERS jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XERS
1D Price
Change %
XERS100%
+0.42%
TRDA - XERS
53%
Loosely correlated
-0.55%
AURA - XERS
45%
Loosely correlated
+1.55%
YMAB - XERS
45%
Loosely correlated
+0.94%
XNCR - XERS
45%
Loosely correlated
+1.45%
CGON - XERS
44%
Loosely correlated
+0.82%
More